Metformin and the risk of cancer: time-related biases in observational studies - Test2 - elhamkhani - TriplyDB

Metformin and the risk of cancer: time-related biases in observational studies

Metformin and the risk of cancer: time-related biases in observational studies

http://www.wikidata.org/entity/Q26999266

about

Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality Diabetes mellitus and metformin in hepatocellular carcinoma Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis Obesity and cancer: mechanistic insights from transdisciplinary studies Why does obesity promote cancer? Epidemiology, biology, and open questions AMPK: a target for drugs and natural products with effects on both diabetes and cancer Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis Dissecting the Dual Role of AMPK in Cancer: From Experimental to Human Studies Pharmacologic Therapy of Diabetes and Overall Cancer Risk and Mortality: A Meta-Analysis of 265 Studies Proton pump inhibitors and risk of periampullary cancers--A nested case-control study Risk of tuberculosis in patients with diabetes: population based cohort study using the UK Clinical Practice Research Datalink Diabetes Care: “state of the union”Renin-angiotensin system blockade for the risk of cancer and death.Using Large Diabetes Databases for Research.Can commonly prescribed drugs be repurposed for the prevention or treatment of Alzheimer's and other neurodegenerative diseases? Protocol for an observational cohort study in the UK Clinical Practice Research Datalink.Higher risk of colorectal cancer in patients with newly diagnosed diabetes mellitus before the age of colorectal cancer screening initiation A novel method for studying the temporal relationship between type 2 diabetes mellitus and cancer using the electronic medical record Use of metformin and survival of diabetic women with breast cancer Meta-analysis of studies using metformin as a reducer for liver cancer risk in diabetic patients.Type 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy.Incidence of bladder cancer in patients with type 2 diabetes treated with metformin or sulfonylureas.Specific metabolic biomarkers as risk and prognostic factors in colorectal cancer.Type 2 diabetes, socioeconomic status and risk of cancer in Scotland 2001-2007.Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders.Metformin and cancer.Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial.Metformin and the risk of cancer in type 2 diabetes: methodological challenges and perspectives Metformin is not just an antihyperglycaemic drug but also has protective effects on the vascular endothelium.Assessing the effect of treatment duration on the association between anti-diabetic medication and cancer risk LKB1 and AMPK and the cancer-metabolism link - ten years after Metformin and erlotinib synergize to inhibit basal breast cancer.Use of insulin and insulin analogs and risk of cancer - systematic review and meta-analysis of observational studies.Metformin and breast and gynecological cancer risk among women with diabetes.Metformin use and lung cancer risk in patients with diabetes.Chemopreventive strategies in hepatocellular carcinoma Changes in insulin receptor signaling underlie neoadjuvant metformin administration in breast cancer: a prospective window of opportunity neoadjuvant study.Association between metformin use and progression of monoclonal gammopathy of undetermined significance to multiple myeloma in US veterans with diabetes mellitus: a population-based retrospective cohort study.Risk of cancer among patients with depressive disorder: a meta-analysis and implications.Are metformin, statin and aspirin use still associated with overall mortality among colorectal cancer patients with diabetes if adjusted for one another?

P2860

Q24745996-161A56A3-6190-496D-B0B4-3363803B5417 Q26741205-4141C172-C451-4CEC-A323-69F1FCF6504E Q26751511-04E6FC22-BD0A-493D-8AF8-CD38F3D3A525 Q26765139-39BD2448-FDE3-4CCF-A179-360E009B15D9 Q26786829-68C780DA-D4EB-4D25-A3C7-BAA4772D19B4 Q26797301-C69DAF17-1032-414B-B557-4E0C92D8F6B6 Q27002908-DC5BF6A1-C3B4-4DB7-98AF-CBA6386593CB Q28074225-23648E83-1FFF-47A0-9E00-3B262AEE743A Q28081491-EB7B98E5-2834-4296-A6A3-6095C92815B7 Q28084927-7BA980EA-1CF2-48AA-9880-FFD8443C7D49 Q28385784-396FEA32-F7FC-43E1-AA47-16D24026F09B Q28648322-4C743442-160D-4381-AE6E-C452AC2CE9C4 Q28710273-26DA0BEA-12EA-4D11-AA37-811245839A31 Q30249043-4434C8F0-0E38-4D7B-A572-3970B45B7DFB Q30251480-5C53D726-3A38-43F5-898B-8983FA5D440B Q30490505-EB9C12FD-21BA-4969-B472-24F22753F675 Q33594200-B693E3B4-84B3-4078-8A45-7946E0BA0FD5 Q33617565-4A85DF34-3EFB-4A19-A3DD-E532E2EB5FF7 Q33646542-D01B532A-DAD8-40CD-992B-D17AB077FF2C Q33672932-1C492A39-BC4B-487F-8D25-A12C06AA3206 Q33756414-7E4B2A22-1DDA-413C-A9D1-917042A68D55 Q33793812-F4AF5F9F-47F7-421C-AF0C-7D9E17A2C222 Q34008787-83E89490-2CFA-473E-BE8D-B5AA8A9E7D60 Q34038229-BEA6D145-18D2-4C7F-894C-20B62815E650 Q34135248-F4A60D67-D602-4C38-A864-3FB670D2C320 Q34159241-BA71CAD4-4A91-48C4-B812-2E06184A142D Q34334262-9DB01302-8DAF-4D89-968F-A17A4F90C4C1 Q34357944-616D7DB2-65A1-44ED-95E5-F965C00FB4BA Q34505650-5D05D8A3-E207-4587-A173-E8DEA59C7B1A Q34565654-0344C478-9984-4BB0-BECF-1CDE1206C866 Q34669215-2DC40E2E-1175-464D-972A-914498C7338B Q34786488-A36537B6-CC56-4324-8960-AD88D8488D94 Q35038355-01FF52CA-F779-41BB-97BC-50360ED7FB33 Q35046074-A902B126-0845-405F-83DE-6934E6CC115A Q35046673-D8449139-556B-4A2E-AF1E-D71D7491BF3E Q35101365-64B4202E-21A6-4E2C-A860-1E5BAD5D54CA Q35238162-3053CD61-D502-4944-96AE-8B3C91C82C3D Q35664299-A876870F-A9FA-4883-9FFB-C5A5ECC0EA57 Q35904472-24146F97-B578-4D97-9B74-0D54506F99C3 Q35909683-E1271D1B-6FB9-4E70-9395-4D54B0F65DFC

P2860

Metformin and the risk of cancer: time-related biases in observational studies

http://www.wikidata.org/entity/Q26999266

description

2012 nî lūn-bûn

@nan

2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Metformin and the risk of cancer: time-related biases in observational studies

@ast

Metformin and the risk of cancer: time-related biases in observational studies

@en

Metformin and the risk of cancer: time-related biases in observational studies

@nl

type

label

Metformin and the risk of cancer: time-related biases in observational studies

@ast

Metformin and the risk of cancer: time-related biases in observational studies

@en

Metformin and the risk of cancer: time-related biases in observational studies

@nl

prefLabel

Metformin and the risk of cancer: time-related biases in observational studies

@ast

Metformin and the risk of cancer: time-related biases in observational studies

@en

Metformin and the risk of cancer: time-related biases in observational studies

@nl

P1433

Q26999266-BC484FAA-06BB-4EF2-BBE4-F09AC0189175

P1476

Q26999266-8DF6FE95-B91E-40D6-B2A1-70445338CB10

P2093

Q26999266-475CB95B-790C-4F75-9C6F-82DC7FF5F9EF

Q26999266-ADA9F5FB-5A3B-452C-AC36-D4AD5ABDF0B1

P275

Q26999266-3791B98B-95EE-4AAE-9FEB-33301CB1DA16

P2860

Q26999266-03691CCF-7471-441B-8AD5-DBB48F80400D

Q26999266-0B8B2F3F-FFF7-42F1-AE48-B9BA3AB104E0

Q26999266-14B67572-C333-4A78-BC38-4B39265F0599

Q26999266-1935404E-9EB2-42D6-A8CC-AFD7BF314BCD

Q26999266-1A9D3F89-1DE4-41CA-A22B-2A86C6B4CE30

Q26999266-210AA783-CF7A-45CC-A75F-84D421607C5A

Q26999266-2C1D8883-F869-4949-9B00-1150A722EE42

Q26999266-2D714821-BCC7-445E-AB6D-E3EB3D7BC1F4

Q26999266-3F651D89-1E8E-45CC-9D29-979E8A55C821

Q26999266-428238A8-0809-47E1-8C39-3D52F6D0D92D

P304

Q26999266-290412A4-61EA-4EBA-88FE-03ADA4348852

P31

Q26999266-A81DD6FB-ADDF-47D5-85EC-80EF2CCCB299

Q26999266-ED3E4A99-1C57-4B27-85C1-6EBA94B59AAB

P3181

Q26999266-6423A7CF-EE90-4D36-AE30-8E831CBCDC80

P356

Q26999266-F2DF6C95-DFDB-4323-82B0-03889CFB5771

P407

Q26999266-409021E4-5C7B-4D86-BAD5-8C39C8000FA0

P433

Q26999266-7B02887C-B6A4-4C53-97BD-75BEFF70AE8A

P478

Q26999266-71C89BF7-FE7D-4B5F-A4A1-7C267687312F

P577

Q26999266-7AAE171E-75A3-495B-8B51-1CB819ADC226

Q26999266-ECEF5323-D822-4379-A598-441222D5A0C4

P5875

Q26999266-B91DAEC6-0FEB-4B23-A87C-408243E5E117

P698

Q26999266-2B0EE554-5D57-42E4-B6B7-3EED499275A3

P921

Q26999266-17D5A12A-354E-457F-AABC-B69E3C65E7BC

Q26999266-B8696004-33A1-4AA8-9B32-63E56BFCEAC8

Q26999266-F4282B37-9E1A-49ED-9CAC-00592CC1EB74

P932

Q26999266-6A54C9D9-9DC0-49C4-9CBE-D4EC16634669

P3181

P356

P1433

P1476

Metformin and the risk of cancer: time-related biases in observational studies

@en

P2093

L. Azoulay

http://www.w3.org/2001/XMLSchema#string

S. Suissa

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivatives

P2860

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease

Metformin in breast cancer: time for action

Metformin and reduced risk of cancer in diabetic patients

Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16

Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.

Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals.

Long-term metformin use is associated with decreased risk of breast cancer.

Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma.

Metformin and cancer occurrence in insulin-treated type 2 diabetic patients.

P304

2665-73

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1814007

http://www.w3.org/2001/XMLSchema#string

P356

10.2337/DC12-0788

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233746365

http://www.w3.org/2001/XMLSchema#string

P698

23173135

http://www.w3.org/2001/XMLSchema#string

P921

P932

3507580

http://www.w3.org/2001/XMLSchema#string